TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
LipoTrue introduced three cosmetic active ingredients at in-cosmetics Asia 2026: Glintarine, Red Aternaliss and Kalizyme. The company describes them as formulation options for radiance, skin longevity and epidermal renewal; performance statements in the launch material are company claims, and independent test details were not provided.
LipoTrue introduced three cosmetic active ingredients at in-cosmetics Asia 2026, presenting Glintarine, Red Aternaliss and Kalizyme as formulation options for skin radiance, longevity and epidermal renewal. The launches expand the company’s portfolio for cosmetic formulators, but the available announcement does not provide detailed study methods or independent evidence for its stated skin benefits.
The ingredients take different approaches, according to LipoTrue’s launch information. Glintarine is a marine ferment inspired by the sea surface microlayer, described as the boundary between ocean water and light. The company says it is designed to regulate melanin dynamics during epidermal renewal, supporting pigment redistribution and clearance. It combines depigmenting, exfoliating and antioxidant activities, and LipoTrue reports that visible results may appear from the first week. The announcement does not specify how that timing was assessed or provide the study design behind it.
Red Aternaliss combines Edelweiss stem cells and red algae extracts. LipoTrue describes it as a cellular longevity active intended to address the nine Hallmarks of Aging, supporting genomic protection, regeneration, cellular resilience and epidermal integrity. The company says the ingredient is intended to help maintain skin function and renewal over time, with a resulting appearance that is smoother, more radiant and younger-looking. Those are product-positioning and performance claims in the company material; it does not detail evidence supporting each proposed effect.
Kalizyme is described as a biomimetic enzyme modeled on human KLK7 and produced through LipoTrue’s Wild Plants as Biofactories technology. Inspired by natural desquamation, the process by which the outer skin sheds cells, it is intended to provide controlled exfoliation while maintaining skin comfort. The company says its activity combines exfoliation with active regeneration to support balanced epidermal renewal. LipoTrue presented the three launches as complementary ingredients for products focused on luminosity, healthy aging, gentle exfoliation and the visible quality of renewed skin.
Three Routes for Cosmetic Formulators
The launches matter primarily to cosmetic formulators and ingredient buyers: they offer three distinct concepts that can be considered for products addressing uneven-looking tone, visible signs of aging or exfoliation. Rather than one ingredient with a single shared mechanism, LipoTrue is positioning the trio around different biological ideas—marine fermentation, plant and algae extracts, and a biomimetic enzyme.
That distinction may help brands develop products with more specific ingredient stories and targeted positioning. However, the announcement alone does not establish how the actives perform in finished products, how they compare with existing ingredients, or whether the proposed benefits hold across skin types. For consumers, the launches indicate new ingredients are being offered to the cosmetics industry, not that a finished product is already available or that clinical benefits have been independently demonstrated.
Popular right now
Shark Rotator Lift-Away Upright Vacuum with HEPA Filter (NV501)
De'Longhi 15-Bar Pump Espresso Machine with Milk Frother & Temperature Control
Bose QuietComfort True Wireless Noise-Cancelling Earbuds, Black
As an affiliate, we earn on qualifying purchases.
The Ingredients Behind the Launch
The launches were presented as part of LipoTrue’s portfolio expansion at in-cosmetics Asia 2026, a trade event for the cosmetics and personal-care industry. The company said visitors could see the ingredients at booth V50. The report identifies the intended audience as formulators seeking targeted cosmetic solutions, rather than consumers shopping for a named retail product.
LipoTrue frames the three ingredients as nature-inspired biotechnology. Glintarine draws on a marine environment; Red Aternaliss brings together plant stem cells and red algae; and Kalizyme uses the company’s Wild Plants as Biofactories platform to produce an enzyme modeled on KLK7. The shared theme is translating biological processes into ingredients for cosmetic formulations, while each launch is associated with a separate product-development focus.
Evidence and Product Details Not Disclosed
The source announcement does not provide study protocols, participant numbers, test conditions or full results for the performance statements. It is not clear what supports the claim that Glintarine can produce visible results from the first week, how Red Aternaliss’s proposed effects across nine aging hallmarks were evaluated, or what testing supports Kalizyme’s balance of exfoliation and comfort. The material also does not give ingredient concentrations, formulation compatibility, pricing or a timetable for products containing the actives.
The claims should be read as company descriptions of intended cosmetic effects, not as independently verified findings. Further information from LipoTrue or from formulators using the ingredients would be needed to establish how they perform in particular finished products and under what conditions.
Formulator Access and Further Data
LipoTrue said visitors could learn about Glintarine, Red Aternaliss and Kalizyme at booth V50 during in-cosmetics Asia 2026. The next relevant developments are likely to include technical information for formulators and announcements from brands that choose to incorporate the ingredients into finished products. The launch material does not name any partner brands or set a date for consumer products.
For a clearer assessment of the ingredients’ practical value, formulators and buyers would need additional details on testing, recommended use levels, formulation performance and the substantiation for each benefit claim. Until those details are available, the confirmed development is the portfolio launch and the ingredients’ stated intended applications.
Key Questions
What did LipoTrue introduce?
LipoTrue introduced Glintarine, Red Aternaliss and Kalizyme at in-cosmetics Asia 2026 as cosmetic active ingredients for formulation development.
What is each ingredient intended to do?
The company positions Glintarine for radiance and the appearance of uneven tone, Red Aternaliss for skin longevity and resilience, and Kalizyme for exfoliation and epidermal renewal.
Are the stated benefits independently verified?
The available launch report does not provide enough study detail to establish that. The performance descriptions are claims attributed to LipoTrue; independent evidence and testing methods were not included.
Are these finished skincare products for consumers?
No finished retail products are identified in the announcement. The launches are ingredients for cosmetic formulators, and the company did not name brands using them or provide a consumer-product release date.
Source: cosmeticsbusiness.com
